Sarah Wells Kocsis, MBA, is co-author of the Milken Institute report, “Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management.” She spoke to The American Journal of Managed Care® about the findings of the report and how they can be incorporated into care for patients with chronic kidney disease (CKD).
Sarah Wells Kocsis, MBA, director of the Center for Public Health at the Milken Institute, talks about the implications of climate change and aging patients on chronic kidney disease (CKD) care in her recently authored report, “Chronic Kidney Disease: Finding a Path to Prevention, Earlier Detection, and Management.”
Transcript
What are the biggest implications of climate change and the aging population on CKD care?
Another very thoughtful question. Climate change and our increasing aging population are really what's going to define the future of health. And both of them are obviously having [an] impact [on] and implications for everyone in society and on the planet, but there are some certain groups and their health that are impacted more than others. Increasingly susceptible to CKD are outdoor laborers, such as agricultural workers. And then among our seniors, there's a cohort of seniors that are living in isolation, they're living in poverty, and they're struggling with food insecurity. These subset populations are particularly at risk when we're talking about the impact of climate change and aging.
When we were doing this report, we worked with thought leaders who are experts in the space and one of them made a comment that really resonated with our team. That was that CKD is really a mirror of many of the things that are so wrong with our health care system. So I think that when you step back and reflect on that, it really sums up what a growing public health threat we're facing, both at the societal level with those big changes you mentioned, but also the fact that there's just so many health equity gaps that are making CKD also a humanitarian crisis as well.
And so, the report that we wrote, really brings heightened awareness around CKD and it's really trying to call to action all members across the community to come together to respond.
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
FDA Approves Vadadustat for Anemia in Patients With CKD Undergoing Dialysis
March 28th 2024The FDA approved vadadustat (Vafseo), an oral medication, to treat anemia in adult patients with chronic kidney disease (CKD) on dialysis for at least 3 months. This fills a need for a new treatment option as anemia is common in these patients and can significantly impact their quality of life.
Read More
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More